ReviewTreatment of HER2-positive breast cancer
Under a Creative Commons license
open access
Keywords
HER2-positive breast cancer
Trastuzumab
Pertuzumab
Lapatinib
Cited by (0)
- 1
Both authors equally contributed to this manuscript.
Copyright © 2013 Elsevier Ltd. All rights reserved.